[Acute leukemia and breast cancer : apropos of 12 cases observed in the Department of Oncology at the Henri Mondor Hospital].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6667351)

Published in Bull Cancer on January 01, 1983

Authors

F Feuilhade, B Brun, A Tuhran, J P Vernant, Y Otmezguine, H Rochant, B Pierquin

Articles by these authors

Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) (1996) 4.52

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet (1998) 3.62

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41

Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome. Br J Haematol (2003) 2.36

Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia (2004) 1.81

Radical radiation therapy of breast cancer. Int J Radiat Oncol Biol Phys (1980) 1.75

Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192. Radiother Oncol (1991) 1.50

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant (2000) 1.44

Dosimetry of intraluminal brachytherapy. Radiother Oncol (1992) 1.43

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood (1998) 1.42

A human minor histocompatibility antigen which appears to segregate with the major histocompatibility complex. Transplantation (1994) 1.39

Evolution of bacterial susceptibility to antibiotics during a six-year period in a haematology unit. J Hosp Infect (1995) 1.39

Absence of graft-versus-leukemia (GVL) effect by leucocytes transfused: a prospective randomized trial in acute myeloid leukemia (AML) patients. Br J Haematol (1991) 1.37

Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM). Blood (1995) 1.36

Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol (2001) 1.36

Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders. J Clin Oncol (2001) 1.35

Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM). Br J Haematol (1997) 1.33

Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation. J Immunol (1986) 1.25

Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases. Br J Haematol (1988) 1.23

Myeloid and megakaryocytic properties of K-562 cell lines. Cancer Res (1983) 1.23

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. Hematol Oncol Clin North Am (2000) 1.22

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol (2001) 1.21

[Thrombotic microangiopathy and its ocular manifestations: an unusual complication of bone marrow graft]. J Fr Ophtalmol (1983) 1.19

The Paris system in interstitial radiation therapy. Acta Radiol Oncol Radiat Phys Biol (1978) 1.18

Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology (1987) 1.18

Acute promyelocytic leukemia in 57 previously untreated patients. Cancer (1985) 1.14

Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br J Haematol (2000) 1.12

Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation (1998) 1.11

Massive blastic infiltration of the liver: a cause of fulminant hepatic failure. Hepatology (1983) 1.11

Anomalies of blood group antigens and erythrocyte enzymes in two types of chronic refractory anaemia. Br J Haematol (1969) 1.08

Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. J Clin Invest (1998) 1.08

Erdheim-Chester disease presenting as malignant exophthalmos. Br J Radiol (1986) 1.08

[Refractory anemias: acquired enzymopathies of hematopoietic stem cells]. Nouv Rev Fr Hematol (1969) 1.08

A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol (1997) 1.07

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study. Leukemia (2006) 1.07

Radiation therapy in the management of primary breast cancer. AJR Am J Roentgenol (1976) 1.06

Regulation of transferrin receptors in human hematopoietic cell lines. J Biol Chem (1984) 1.06

T-cell lymphoma revealed by a peripheral neuropathy. A report of two cases with an immunohistologic study on lymph node and nerve biopsies. Cancer (1986) 1.05

Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer (1986) 1.05

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. J Clin Oncol (1994) 1.05

[Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases]. Rev Med Interne (2002) 1.04

Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. Blood (1995) 1.03

Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura. Br J Haematol (2006) 1.02

Graft versus host reaction and lichen planus. Br J Dermatol (1975) 1.01

Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. J Am Acad Dermatol (1992) 0.99

Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery. Stroke (1987) 0.99

Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: a case report with a four-year follow-up. J Bone Joint Surg Am (1997) 0.98

Carbonic anhydrase I is an early specific marker of normal human erythroid differentiation. Blood (1985) 0.98

Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood (1987) 0.98

Ultrasonography, computed tomography, and cholescintigraphy in suspected obstructive jaundice--a prospective comparative study. Gastroenterology (1983) 0.97

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet (2000) 0.97

Silent cerebral infarction in chronic atrial fibrillation. Stroke (1988) 0.97

[New immunologic classification of the hemolytic anemias with autoantibodies]. Nouv Rev Fr Hematol (1968) 0.97

Interstitial radiation therapy for carcinoma of the penis using iridium 192 wires: the Henri Mondor experience (1970-1979). Int J Radiat Oncol Biol Phys (1984) 0.97

Nephrotic syndrome associated with T-cell lymphoma. Cancer (1981) 0.97

Hemin regulates the expression of transferrin receptors in human hematopoietic cell lines. FEBS Lett (1982) 0.96

The role of iron in the growth of human leukemic cell lines. J Cell Physiol (1984) 0.96

Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogeneic bone marrow transplantation. Am Rev Respir Dis (1985) 0.96

Respiratory distress of hyperleukocytic granulocytic leukemias. Cancer (1979) 0.96

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial). Br J Cancer (1999) 0.96

Late toxoplasmosis evidenced by PCR in a marrow transplant recipient. Bone Marrow Transplant (1995) 0.95

Toward consistent local control of certain malignant tumors. Endoradiotherapy with iridium 192. Radiology (1971) 0.95

Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer. Ann Oncol (1994) 0.94

[Plesiocurietherapy of vaginal cancers by plastic mold with iridium 192 (non-radioactive preparation). (Preliminary note)]. J Radiol Electrol Med Nucl (1966) 0.93

[Prospects offered by a computer program on calculating dosage in gynecologic curietherapy]. J Radiol Electrol Med Nucl (1970) 0.93

Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type. Ann Oncol (2007) 0.93

Transferrin binding to K562 cell line. Effect of heme and sodium butyrate induction. Exp Cell Res (1982) 0.92

[Radiation-induced sarcoma after breast cancer. Apropos of 8 cases and review of the literature]. Cancer Radiother (1998) 0.92

The past and future of conservative treatment of breast cancer. Am J Clin Oncol (1986) 0.92

[Description and initial trial of the curetron (polyvalent projector of radioactive sources permitting complete protection in gynecologic curietherapy)]. J Radiol Electrol Med Nucl (1969) 0.92

Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplant (1996) 0.92

Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles. Blood (1999) 0.91

Apoptosis of myofibres and satellite cells: exercise-induced damage in skeletal muscle of the mouse. Neuropathol Appl Neurobiol (1998) 0.90

Pseudo-Chediak-Higashi anomaly in a case of acute myeloid leukemia: electron microscopic studies. Blood (1979) 0.90

Time factors in breast carcinoma: influence of delay between external irradiation and brachytherapy. Radiother Oncol (1992) 0.89

Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation. Bone Marrow Transplant (2012) 0.89

Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia (2006) 0.89

Influence of clinical status on the efficiency of stored platelet transfusion. Br J Haematol (1994) 0.89

Usefulness of consensus conferences: the case of albumin. Lancet (1992) 0.89

Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1996) 0.89

The blast crisis of chronic granulocytic leukaemia: megakaryoblastic nature of cells as revealed by the presence of platelet-peroxidase--a cytochemical ultrastructural study. Br J Haematol (1978) 0.89

Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1999) 0.89

[Mückle-Wells syndrome. 5th familial case]. Nouv Presse Med (1972) 0.89

[Diffuse interstitial fibrosis of the lung in Hodgkin's disease treated by high doses of endoxan]. Bull Mem Soc Med Hop Paris (1968) 0.88

Radiological changes of the hands in systemic sclerosis. Acta Derm Venereol (1983) 0.87

Conservative treatment of breast cancer: results of management of axillary lymph node area in 3353 patients. Lancet (1985) 0.87

Lambda cold agglutinin with anti-A 1 specificity in a patient with reticulosarcoma. Vox Sang (1972) 0.87

Meiotic study of hybrids in the genus Eulemur and taxonomic considerations. Am J Primatol (1997) 0.87

Long-term results of neoadjuvant radiation therapy for breast cancer. Int J Cancer (2001) 0.86

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission. Blood (2001) 0.86

One century of radiotherapy in France 1896-1996. Int J Radiat Oncol Biol Phys (1996) 0.86

Impact of magnetic resonance imaging on the diagnosis of abdominal complications of paroxysmal nocturnal hemoglobinuria. Blood (1995) 0.86

Erythroid properties of K562 cells. Effect of hemin, butyrate and TPA induction. Exp Cell Res (1983) 0.86

The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines. Br J Haematol (1985) 0.86